Vaccine Distributor McKesson's Stock Is Up 22% This Year. It Can Go Higher, Morgan Stanley Says.

Retrieved on: 2020-12-24 17:26:15

Tags for this article:

Click the tags to see associated articles and topics

Vaccine Distributor McKesson's Stock Is Up 22% This Year. It Can Go Higher, Morgan Stanley Says.. View article details on hiswai:

Excerpt

Morgan Stanley's Ricky Goldwasser figures that the Moderna (MRNA) shots alone could be worth as much as $1 billion to McKesson's 2021 revenue ...

Article found on: www.barrons.com